Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Naglaa Shoukry, Ph.D.

Professor, Department of Medicine, Director, Viral Hepatitis Research Group at University of Montreal


Dr. Shoukry obtained her Pharmacy degree from Cairo University (1991) and Ph.D. in Immunology from McGill University (2000).  Her postdoctoral research has established the essential and complementary roles of CD8 and CD4 T lymphocytes in resolution and protection from HCV infection.  Since joining the Université de Montréal and CRCHUM in 2005, she has established a translational research program focused on studying immunity to HCV in a unique cohort of people who inject drugs. Recently, her research has expanded to studying immunological mechanisms of liver fibrosis progression and development of liver cancer. She has published over 60 articles in high impact journals related to liver immunology and has received multiple awards from the American Liver Foundation, the Canadian Institutes of Health Research (CIHR) and Fonds de recherche du Québec – Santé (FRQS).  In June 2014, she was selected to lead the application for the Canadian Network on Hepatitis C (CanHepC) that was funded in 2015 for $4.5 million to establish a pipeline from research to implementation and to improve the lives of Canadians living with hepatitis C.

Agenda Sessions